Latest news
Guidance for new Marketing Authorisation assessment routes in the UK following Brexit

In the intro of a series of articles, Nasos Kipentzoglou, Analyst at Lightning API provides a round up of the current mechanisms to obtain marketing authorisation in the UK

The G-BA implements post launch real world evidence generation for Zolgensma®

Nasos Kipentzoglou, Analyst at Lightning API reviews the recent approach that the G-BA has taken in requiring the mandatory collection of real world evidence for Zolgensma®

NICE rejects gene therapy Zynteglo

Following NICE draft guidance rejecting Zynteglo, Eleanor Butler, Consultant at Lightning API explores why the beta thalassaemia treatment is not recommend for routine NHS funding

Implications of the UK Rare Diseases Framework for rare disease patients and manufacturers developing new treatments

Nancy Cross, Analyst, and Eleanor Butler, Consultant at Lightning API review the recently published framework and discuss what this means for stakeholders

60 seconds with Nancy Cross, Analyst

60 seconds with Nancy Cross, Analyst

Happy Festive Season

The team at Lightning API would like to…

60 seconds with Nasos Kipentzoglou, Analyst

60 seconds with Nasos Kipentzoglou, Analyst

Lightning API’s recently published research in ATMPs further explores the key themes discussed at the virtual ISPOR Europe 2020

Lightning API attended the virtual ISPOR Europe 2020, here is our round up of the meeting.

60 seconds with Joshua Beddow, Junior Analyst

60 seconds with Joshua Beddow, Junior Analyst

60 seconds with Alice Best, Platform and Operations Manager

60 seconds with Alice Best, Platform and Operations Manager

60 seconds with Eleanor Butler, Consultant

60 seconds with Eleanor Butler, Consultant

Why and how to use qualitative research methods in conjunction with discrete choice experiments in healthcare

This week our colleagues Eleanor Butler and Marina Kousta attended an ISPOR webinar, read their blog.

60 seconds with Marina Kousta, Analyst

60 seconds with Marina Kousta, Analyst

60 seconds with Stuart Hurst, Executive Advisor (Launch Excellence)

60 seconds with Stuart Hurst, Executive Advisor (Launch Excellence)

60 seconds with Andrew Satherley, Joint Managing Director

60 seconds with Andrew Satherley, Joint Managing Director

60 seconds with James Whitehouse, Joint Managing Director

60 seconds with James Whitehouse, Joint Managing Director

UK parliament steps up plans for medicines access post Brexit

The UK parliament has published contingency legislation to ensure continuity of medicines access and clinical trials in the event of a no deal Brexit.

Dr Frances Macdonald joins the Lightning API network

The Lightning API team is delighted to announce Dr Frances Macdonald is joining the network as an executive advisor for European HTA.

The NHS England long term plan

NHS England has published its long-awaited long-term NHS plan, setting out the strategic objectives for the NHS over the next 10 years.